Pharmacokinetic and pharmacodynamic requirements for antibiotic therapy of experimental endocarditis.
作者信息
Cremieux A C, Carbon C
机构信息
Service de Médecine Interne, Institut National de la Santé et de la Recherche Médicale U13, Hopital Bichat-Claude Bernard, Paris, France.
出版信息
Antimicrob Agents Chemother. 1992 Oct;36(10):2069-74. doi: 10.1128/AAC.36.10.2069.
Abstract
摘要
相似文献
1
Pharmacokinetic and pharmacodynamic requirements for antibiotic therapy of experimental endocarditis.实验性心内膜炎抗生素治疗的药代动力学和药效学要求。
Antimicrob Agents Chemother. 1992 Oct;36(10):2069-74. doi: 10.1128/AAC.36.10.2069.
2
Pharmacokinetic and pharmacodynamic aspects of therapy of experimental endocarditis.
Infect Dis Clin North Am. 1993 Mar;7(1):37-51.
3
"Difficult to treat infections" pharmacokinetic and pharmacodynamic factors--a review.“难治性感染”的药代动力学和药效学因素——综述
Acta Microbiol Immunol Hung. 2000;47(1):1-8.
4
[Antibiotic treatment of endocarditis : Partial Oral Treatment of Endocarditis Trial (POET)].
Internist (Berl). 2019 Jul;60(7):769-772. doi: 10.1007/s00108-019-0600-0.
5
The long journey of outpatient parenteral antibiotic therapy in infective endocarditis: from idea to clinical guidelines.
South Med J. 2009 Jun;102(6):559-60. doi: 10.1097/SMJ.0b013e3181a59750.
6
Cochrane corner: a comparison of antibiotic regimens for the treatment of infective endocarditis.考克兰专栏：治疗感染性心内膜炎的抗生素方案比较
Heart. 2021 Mar;107(5):355-357. doi: 10.1136/heartjnl-2020-317891. Epub 2020 Dec 23.
7
[Contribution of the experimental model of bacterial endocarditis].
Bull Acad Natl Med. 1995 Apr;179(4):767-74; discussion 775-6.
8
Assessment of the feasibility of a partial oral regimen for antibiotic therapy of endocarditis.
Intern Emerg Med. 2019 Apr;14(3):475-477. doi: 10.1007/s11739-019-02067-7. Epub 2019 Mar 12.
9
[Antibiotic treatment of severe bacterial diseases in internal medicine (sepsis, meningitis, endocarditis)].[内科严重细菌性疾病（败血症、脑膜炎、心内膜炎）的抗生素治疗]
Dtsch Med J. 1972 Apr 9;23(4):275-80.
10
Guidelines for the antibiotic treatment of endocarditis in adults: report of the Working Party of the British Society for Antimicrobial Chemotherapy.成人感染性心内膜炎抗生素治疗指南：英国抗菌化疗协会工作组报告
J Antimicrob Chemother. 2004 Dec;54(6):971-81. doi: 10.1093/jac/dkh474. Epub 2004 Nov 16.
引用本文的文献
1
Antimicrobial Use Among Outpatients at Benjamin Mkapa Hospital in Dodoma Central Zone of Tanzania: A Prospective Descriptive Study.坦桑尼亚多多马中心区本杰明·姆卡帕医院门诊患者的抗菌药物使用情况：一项前瞻性描述性研究。
Infect Dis Clin Microbiol. 2024 Sep 26;6(3):174-184. doi: 10.36519/idcm.2024.394. eCollection 2024 Sep.
2
Anti-biofilm Approach in Infective Endocarditis Exposes New Treatment Strategies for Improved Outcome.感染性心内膜炎中的抗生物膜方法揭示了改善预后的新治疗策略。
Front Cell Dev Biol. 2021 Jun 18;9:643335. doi: 10.3389/fcell.2021.643335. eCollection 2021.
3
Investigation of antimicrobial use at a tertiary care hospital in Southern Punjab, Pakistan using WHO methodology.采用世界卫生组织方法对巴基斯坦旁遮普省南部一家三级护理医院的抗菌药物使用情况进行调查。
Antimicrob Resist Infect Control. 2017 Apr 28;6:41. doi: 10.1186/s13756-017-0199-7. eCollection 2017.
4
WHO/INRUD prescribing indicators and prescribing trends of antibiotics in the Accident and Emergency Department of Bahawal Victoria Hospital, Pakistan.世界卫生组织/国际合理用药网络（WHO/INRUD）在巴基斯坦巴哈瓦尔维多利亚医院急诊科的抗生素处方指标及处方趋势
Springerplus. 2016 Nov 8;5(1):1928. doi: 10.1186/s40064-016-3615-1. eCollection 2016.
5
Pharmacokinetic and Pharmacodynamic Principles of Anti-infective Dosing.抗感染药物剂量的药代动力学和药效学原理。
Clin Ther. 2016 Sep;38(9):1930-47. doi: 10.1016/j.clinthera.2016.06.015. Epub 2016 Jul 20.
6
Comparison of six generic vancomycin products for treatment of methicillin-resistant Staphylococcus aureus experimental endocarditis in rabbits.比较六种万古霉素仿制药治疗兔耐甲氧西林金黄色葡萄球菌实验性心内膜炎的疗效。
Antimicrob Agents Chemother. 2013 Mar;57(3):1157-62. doi: 10.1128/AAC.01669-12. Epub 2012 Dec 17.
7
Efficacy of garenoxacin in treatment of experimental endocarditis due to Staphylococcus aureus or viridans group streptococci.加替沙星治疗金黄色葡萄球菌或草绿色链球菌所致实验性心内膜炎的疗效。
Antimicrob Agents Chemother. 2004 Jan;48(1):86-92. doi: 10.1128/AAC.48.1.86-92.2004.
8
Dead bugs don't mutate: susceptibility issues in the emergence of bacterial resistance.死菌不会变异：细菌耐药性产生中的易感性问题。
Emerg Infect Dis. 2003 Jan;9(1):10-6. doi: 10.3201/eid0901.020172.
9
Different aminoglycoside-resistant phenotypes in a rabbit Staphylococcus aureus endocarditis infection model.兔金黄色葡萄球菌心内膜炎感染模型中的不同氨基糖苷类耐药表型。
Antimicrob Agents Chemother. 2002 May;46(5):1591-3. doi: 10.1128/AAC.46.5.1591-1593.2002.
10
Antibacterials for the prophylaxis and treatment of bacterial endocarditis in children.用于预防和治疗儿童细菌性心内膜炎的抗菌药物。
Paediatr Drugs. 2001;3(10):703-18. doi: 10.2165/00128072-200103100-00001.
本文引用的文献
1
Studies on the relationship of tissue fluid and blood levels of penicillin.青霉素组织液与血液水平关系的研究。
J Lab Clin Med. 1951 Nov;38(5):712-8.
2
Studies relative to the chemotherapy of bacterial endocarditis.关于细菌性心内膜炎化疗的研究。
Ann Intern Med. 1950 Nov;33(5):1224-31. doi: 10.7326/0003-4819-33-5-1224.
3
Rate of methicillin penetration into normal heart valve and experimental endocarditis lesions.甲氧西林渗入正常心脏瓣膜及实验性心内膜炎病变的速率。
Antimicrob Agents Chemother. 1982 Mar;21(3):456-9. doi: 10.1128/AAC.21.3.456.
4
Once-daily vs. continuous aminoglycoside dosing: efficacy and toxicity in animal and clinical studies of gentamicin, netilmicin, and tobramycin.氨基糖苷类药物每日一次给药与持续给药的比较：庆大霉素、奈替米星和妥布霉素的动物及临床研究中的疗效与毒性
J Infect Dis. 1983 May;147(5):918-32. doi: 10.1093/infdis/147.5.918.
5
Minimal concentrations of aminoglycoside that can synergize with penicillin in enterococcal endocarditis.在肠球菌性心内膜炎中可与青霉素协同作用的氨基糖苷类药物的最低浓度。
Antimicrob Agents Chemother. 1981 Sep;20(3):405-9. doi: 10.1128/AAC.20.3.405.
6
Staphylococcal endocarditis in rabbits treated with a low dose of cloxacillin.用低剂量氯唑西林治疗的兔葡萄球菌性心内膜炎
Antimicrob Agents Chemother. 1984 Mar;25(3):311-5. doi: 10.1128/AAC.25.3.311.
7
Integration of pharmacokinetics and pharmacodynamics of methicillin in curative treatment of experimental endocarditis.
J Antimicrob Chemother. 1984 Dec;14(6):619-31. doi: 10.1093/jac/14.6.619.
8
Cerebrospinal fluid alterations in herpes simplex virus encephalitis.单纯疱疹病毒性脑炎中的脑脊液改变
Rev Infect Dis. 1984 Sep-Oct;6(5):608-18. doi: 10.1093/clinids/6.5.608.
9
10
Penetration of antibiotics into fibrin loci in vivo. 3. Intermittent vs. continuous infusion and the effect of probenecid.
J Infect Dis. 1974 Jan;129(1):73-8. doi: 10.1093/infdis/129.1.73.
Zotero 插件